Overall Vote Recommendation

Yes

Principle Criteria

Free Enterprise

Property Rights

Personal Responsibility

Limited Government

Individual Liberty

Digest

S9 85 proposes revisions to the Texas Family Code concerning the administration of immunizations to children. The bill mandates that healthcare providers obtain written informed consent from an authorized individual before administering any vaccine to a child. This consent must include clear communication about the benefits and risks of the vaccine and must provide information about federal procedures for seeking compensation in cases of vaccine-related injury, as outlined under the National Childhood Vaccine Injury Act.

A key provision of SB 95 is its introduction of civil liability for healthcare providers who fail to secure written informed consent in accordance with the law and whose patient subsequently experiences an adverse reaction that must be reported to the federal Vaccine Adverse Event Reporting System. In such cases, providers could be held liable for damages up to $10,000, along with court and attorney fees.

The bill also prohibits healthcare providers from accepting bonuses, kickbacks, or any form of remuneration from vaccine manufacturers beyond basic administrative costs. If such financial benefits are accepted, any obtained consent is rendered invalid. Violators would be subject to professional disciplinary actions and administrative penalties, including fines of either $5,000 or 10 times the value of the remuneration received, whichever is greater. SB 95 aims to enhance transparency, reduce conflicts of interest in vaccination practices, and reinforce informed consent protections for families.

The originally filed version of Senate Bill 95 and its Committee Substitute share a common focus on strengthening informed consent requirements for childhood immunizations, but the Committee Substitute introduces significant expansions and enforcement mechanisms not present in the initial version.

The original bill centered on requiring that informed consent be obtained before a child receives an immunization, with specific disclosures about vaccine risks, benefits, the Vaccine Injury Compensation Program, and the CDC’s Vaccine Excipient Summary. It also established civil liability of at least $5,000 for providers who fail to obtain consent when a child has an adverse reaction. Importantly, it clarified that general tort reform protections (Civil Practice and Remedies Code Sections 41.003 and 41.004) would not apply to these claims, and it modified liability protections for healthcare providers to exclude those who failed to obtain proper consent.

In contrast, the Committee Substitute broadens both the scope and severity of the bill. It increases the civil liability cap to $10,000 and expands recoverable damages to include all reasonable legal expenses. It further adds prohibitions on healthcare providers accepting any bonuses or kickbacks from vaccine manufacturers, with such actions invalidating any obtained consent. This version also authorizes professional discipline and administrative penalties up to 10 times the value of the remuneration or a minimum of $5,000. These financial and regulatory provisions are entirely new to the Committee Substitute and represent a significant escalation in both oversight and enforcement compared to the originally filed version.

In summary, while the original bill focuses on informed consent and modest civil liability, the Committee Substitute amplifies the enforcement framework by introducing financial prohibitions, invalidating tainted consents, and imposing administrative penalties and disciplinary action, thereby broadening the bill's reach and consequences.

Author (1)

Bob Hall

Co-Author (1)

Kevin Sparks

Contact the Author

Sen. Bob Hall

Capitol Phone:

(512) 463-0102

Capitol Office:

CAP 1E.15

E-Mail:

[email protected]

Visit Official Website

Fiscal Notes

According to the Legislative Budget Board (LBB), SB 95 would not have a significant fiscal implication for the state. It states that any costs associated with implementing the bill's provisions—including the new requirements for written informed consent, prohibitions on financial incentives from vaccine manufacturers, and administrative enforcement mechanisms—could be absorbed using existing agency resources.

Specifically, agencies such as the Texas Medical Board, the Texas Board of Nursing, and the Department of State Health Services are not expected to require additional funding to manage the oversight, enforcement, or disciplinary responsibilities introduced by the bill. This implies that the state infrastructure currently in place for medical regulation and public health administration is deemed sufficient to support the bill’s enforcement without the need for new appropriations.

Similarly, no significant fiscal impact is anticipated at the local government level. Courts and local health entities are expected to handle any potential increase in civil litigation or administrative actions within their existing operational capacities. This finding may help ease concerns among stakeholders about potential new financial burdens at the state or local level.

Vote Recommendation Notes

SB 95 presents a principled and well-structured approach to reinforcing the rights of parents and guardians in making informed healthcare decisions for their children. By mandating that healthcare providers obtain written informed consent prior to administering childhood immunizations—and by holding those providers accountable if they fail to do so—this bill strengthens critical safeguards around personal liberty and informed medical choice.

The bill’s provisions are rooted in widely accepted legal standards and federal guidelines, including the requirement to distribute CDC Vaccine Information Statements and the prohibition against receiving manufacturer bonuses or kickbacks. These safeguards protect against conflicts of interest and ensure transparency in vaccine administration. In placing responsibility for informed consent explicitly on the healthcare provider, SB 95 mirrors expectations in other areas of medical practice and promotes consistent standards of care.

From a liberty-oriented policy perspective, the bill upholds the core values of Individual Liberty and Personal Responsibility. It ensures that families are not only aware of potential risks and benefits but are also protected from improper incentives that could compromise the quality of healthcare decisions. The financial and disciplinary penalties included in the bill are measured, enforceable, and tied directly to noncompliance with the law, reinforcing accountability without overburdening the system.

Importantly, the Legislative Budget Board has determined that SB 95 would have no significant fiscal impact on the state or local governments, indicating it is administratively feasible to implement using current resources.

In light of its careful design, clear objectives, and alignment with liberty principles, Texas Policy Research recommends that lawmakers vote YES on SB 95.

Individual Liberty: The bill robustly supports individual liberty by affirming the right of parents and guardians to make informed medical decisions regarding their children’s immunizations. The bill ensures that healthcare providers must clearly communicate vaccine risks, benefits, and legal protections (such as the National Vaccine Injury Compensation Program) before administering a vaccine. This protects families from coerced or uninformed consent and places decision-making power where it rightly belongs—with the individual, not the institution.
Personal Responsibility: By codifying the obligation for healthcare providers to secure and document informed consent, the bill promotes personal accountability on both sides of the healthcare interaction. Providers are held responsible for adhering to best practices, while parents are empowered to ask informed questions and make deliberate decisions for their children’s health. It underscores the principle that liberty requires both freedom and responsibility in equal measure.
Free Enterprise: The bill introduces restrictions on financial arrangements between healthcare providers and vaccine manufacturers, prohibiting bonuses, kickbacks, or similar incentives. While this limits certain contractual freedoms, it does so to preserve trust in the medical process and avoid conflicts of interest. These safeguards can enhance market integrity and consumer confidence in healthcare providers, though they do impose a regulatory boundary on commercial arrangements.
Private Property Rights: The bill does not restrict the use, ownership, or transfer of property. It focuses instead on professional conduct and administrative standards in healthcare delivery. As such, private property rights are unaffected.
Limited Government: Although the bill expands government oversight by authorizing administrative penalties and disciplinary action, this expansion is narrowly tailored. It does not create new regulatory agencies or broad enforcement mandates. Instead, it leverages existing professional licensing frameworks to ensure compliance. The bill balances the need for oversight with restraint, aiming to uphold liberty through transparency and ethical standards rather than heavy-handed regulation.

View Bill Text and Status